Delos Wealth Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22
Closed -$1K 460
2021
Q4
$1K Buy
+22
New +$596 ﹤0.01% 433

Other funds holding XENT

Delos Wealth Advisors's XENT Position: Q1 2022 in Review

Delos Wealth Advisors sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 22 shares — an estimated $1K sold.

Delos Wealth Advisors first reported a position in XENT in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Delos Wealth Advisors reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
  • Delos Wealth Advisors sold 22 Intersect ENT, Inc shares in Q1 2022, an estimated $1K.
  • Delos Wealth Advisors first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 1 quarter.
  • Delos Wealth Advisors's Intersect ENT, Inc position peaked at $1K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Delos Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.